About the Cancer Immunotherapy Session
Cancer immunotherapy marks a paradigm shift in cancer treatment, leveraging the body's immune system to combat cancer cells. Unlike conventional treatments, such as chemotherapy, immunotherapy empowers the immune system to recognize and eliminate cancerous cells. Techniques like immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines are tailored to target specific cancer types, offering patients a potentially less toxic and more effective alternative. Nevertheless, hurdles persist, including tumor resistance and immune-related adverse effects. Continued research endeavors strive to refine existing strategies and introduce novel approaches, underscoring a promising trajectory in the ongoing battle against cancer.
Topics Covered in Cancer Immunotherapy
Immune Checkpoint Inhibitors
CAR-T Cell Therapy
Therapeutic Vaccines
Immune-Related Toxicity
Resistance Mechanisms
Cytokine Therapy
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Immunotherapy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Immunotherapy work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Immunotherapy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Immunotherapy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Immunotherapy Conference 2027 — FAQs
What is the Cancer Immunotherapy track at CIOC 2027?
The Cancer Immunotherapy track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Immunotherapy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Immunotherapy sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Immunotherapy are all welcome — whether presenting or attending.
Can I present my research in the Cancer Immunotherapy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Immunotherapy sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Immunotherapy track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.